In a report released today, Alexander Paris from Barrington reiterated a Buy rating on Healthequity (NASDAQ: HQY), with a price target of $85. The company’s shares closed yesterday at $76.36, close to its 52-week high of $78.10.
According to TipRanks.com, Paris is a 5-star analyst with an average return of 15.2% and a 69.8% success rate. Paris covers the Services sector, focusing on stocks such as Adtalem Global Education Inc, American Public Education, and Capella Education Company.
Currently, the analyst consensus on Healthequity is Strong Buy and the average price target is $79.25, representing a 3.8% upside.
In a report issued on May 23, Merrill Lynch also initiated coverage with a Buy rating on the stock with a $83 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $78.10 and a one-year low of $40.21. Currently, Healthequity has an average volume of 581.3K.
Based on the recent corporate insider activity of 104 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HealthEquity, Inc. engages in the provision of healthcare saving solutions. Its products include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.
